BiotechTube
Home/Star Therapeutics/Adam Rosenthal, Ph.D.
AR

Adam Rosenthal, Ph.D.

CEO and Founder

Star Therapeutics

Therapeutic Areas

HematologyBleeding Disorders

Star Therapeutics Pipeline

DrugIndicationPhase
VGA039 (VEGA Program)von Willebrand Disease (VWD)Phase 3